Keiko Ihara

Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study

Keiko Ihara, Seiya Ohtani, Narumi Watanabe et al. · The Journal of Headache and Pain · 2023 · 82 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Mesolimbic dopamine release precedes actively sought aversive stimuli in mice

Yosuke Yawata, Yu Shikano, Jun Ogasawara et al. · Nature Communications · 2023 · 24 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Switching between anti-calcitonin gene-related peptide monoclonal antibodies: A comparison of monthly and quarterly dosing

Keiko Ihara, Seiya Ohtani, Narumi Watanabe et al. · Journal of the Neurological Sciences · 2023 · 23 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +12

CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society

Tsubasa Takizawa, Keiko Ihara, Narumi Watanabe et al. · The Journal of Headache and Pain · 2024 · 16 citations · Full text

Medicine, Internal Medicine, Pharmacology +15

Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study

Seiya Ohtani, Narumi Watanabe, Keiko Ihara et al. · BMC Neurology · 2023 · 15 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16